The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Determinants of the clinical expression of amoxicillin‐clavulanate hepatotoxicity: A prospective series from Spain†‡
Open accessAbstract
Amoxicillin-clavulanate (AC) hepatotoxicity has been reported to exhibit a higher predominance of cholestatic types of damage, especially in males. However, the determinants of its clinical expression are unknown. This study prospectively evaluated the profile of AC hepatotoxicity. Data on all cases of hepatotoxicity reported to the Spanish Registry attributed to AC and assessed as definite or probable on the Council for International Organizations of Medical Sciences (CIOMS) scale were collated and compared to published case series. Hepatotoxicity related to amoxicillin-clavulanate was identified in 69 patients (36 males; mean age 56 years) representing 14% of all cases of hepatotoxicity submitted to the Registry. There was an overall sex distribution and the predominant pattern of lesion was hepatocellular (36%) which occurred at a shorter duration of treatment (P < .03). Mean time lapse between therapy initiation and jaundice onset was 16 days. Late onset of symptoms following end of treatment occurred in half the cases. Multiple logistic regression analysis identified advancing age as the factor associated with the development of cholestatic/mixed type of injury (odds ratio for an age interval for 1 year: 1.045 [95% CI = 1.013-1.078; P = .005). An unfavorable outcome was seen in 7% of patients. In conclusion, age is the most important determinant in the biochemical expression of AC hepatotoxicity; younger age is associated with cytolytic damage and shorter treatment duration, whereas cholestatic/mixed type of damage is related to older age and prolonged AC therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Criteria of drug-induced liver disorders
(1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90124-a · Cited by 1,106
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
Variation in antibiotic use in the European Union
Cars, O., Mölstad, S., & Melander, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04972-2 · Cited by 698
Cited by
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study
Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.006 · Cited by 925
Abboud, G., & Kaplowitz, N. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00001 · Cited by 479
Lucena, M. I., Molokhia, M., Shen, Y., Urban, T. J., Aithal, G. P., Andrade, R. J., Day, C. P., Ruiz–Cabello, F., Donaldson, P. T., Stephens, C., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.001 · Cited by 442
Self-citationRisk Factors for Idiosyncratic Drug-Induced Liver Injury
Chalasani, N., & Björnsson, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.001 · Cited by 347
Lucena, M. I., Andrade, R. J., Kaplowitz, N., García‐Cortes, M., Fernández, M. C., Romero‐Gomez, M., Bruguera, M., Hallal, H., Robles‐Diaz, M., Rodriguez‐González, J. F., et al. (2009) · Hepatology · doi:10.1002/hep.22895 · Cited by 290
Self-citationReview article: drug hepatotoxicity
CHANG, C. Y., & SCHIANO, T. D. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03307.x · Cited by 264
Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management
Björnsson, H., & Björnsson, E. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.10.035 · Cited by 212
Idiosyncratic drug-induced liver injury: an overview
Hussaini, S. H., & Farrington, E. A. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.6.673 · Cited by 183
Causality assessment methods in drug induced liver injury: Strengths and weaknesses
García-Cortés, M., Stephens, C., Lucena, M. I., Fernández-Castañer, A., & Andrade, R. J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.007 · Cited by 169
Self-citationComprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
Stephens, C., Robles-Diaz, M., Medina-Caliz, I., Garcia-Cortes, M., Ortega-Alonso, A., Sanabria-Cabrera, J., Gonzalez-Jimenez, A., Alvarez-Alvarez, I., Slim, M., Jimenez-Perez, M., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.029 · Cited by 148
Self-citationGARCÍA‐CORTÉS, M., LUCENA, M. I., PACHKORIA, K., BORRAZ, Y., HIDALGO, R., ANDRADE, R. J., & ON BEHALF OF THE SPANISH GROUP FOR THE STUDY OF DRUG‐INDUCED LIVER DISEASE (GRUPO DE ESTUDIO PARA LAS HEPATOPATÍAS ASOCIADAS A MEDICAMENTOS, G. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03655.x · Cited by 143
Self-citationSundaram, V., & Björnsson, E. S. (2017) · Hepatology Communications · doi:10.1002/hep4.1088 · Cited by 138
Review article: drug‐induced liver injury in clinical practice
Björnsson, E. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04320.x · Cited by 108
Zhu, Y., Niu, M., Chen, J., Zou, Z., Ma, Z., Liu, S., Wang, R., He, T., Song, H., Wang, Z., et al. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13323 · Cited by 86
Drug-induced liver injury in older people
Lucena, M. I., Sanabria, J., García-Cortes, M., Stephens, C., & Andrade, R. J. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30006-6 · Cited by 77
Self-citationChalasani, N., Reddy, R. K. K., Fontana, R. J., Barnhart, H., Gu, J., Hayashi, P. H., Ahmad, J., Stolz, A., Navarro, V., & Hoofnagle, J. H. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.215 · Cited by 75
Nicoletti, P., Dellinger, A., Li, Y. J., Barnhart, H. X., Chalasani, N., Fontana, R. J., Odin, J. A., Serrano, J., Stolz, A., Etheridge, A. S., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2022.11.036 · Cited by 50
Self-citationThe Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
Moreno-Torres, M., Quintás, G., & Castell, J. V. (2022) · Metabolites · doi:10.3390/metabo12060564 · Cited by 50
Weersink, R. A., Alvarez‐Alvarez, I., Medina‐Cáliz, I., Sanabria‐Cabrera, J., Robles‐Díaz, M., Ortega‐Alonso, A., García‐Cortés, M., Bonilla, E., Niu, H., Soriano, G., et al. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2108 · Cited by 29
Self-citationIruzubieta, P., Arias-Loste, M. T., Barbier-Torres, L., Martinez-Chantar, M. L., & Crespo, J. (2015) · BioMed Research International · doi:10.1155/2015/386186 · Cited by 24
Metadata
- Authors
- Lucena, M. I., Andrade, R. J., Fernández, M. C., Pachkoria, K., Pelaez, G., Durán, J. A., Villar, M., Rodrigo, L., Romero‐Gomez, M., Planas, R., Barriocanal, A., Costa, J., Guarner, C., Blanco, S., Navarro, J. M., Pons, F., Castiella, A., & Avila, S.
- Venue
- Hepatology
- Published
- 2006-10
- Volume
- 44
- Issue
- 4
- Pages
- 850-856
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2005831280
- Cited by
- 166
- References
- 3
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.